How much is the stock price of Shire?
Sophia Dalton
Updated on February 08, 2026
How much is the stock price of Shire?
Shire trades on the NASDAQ under the ticker symbol “SHPG.” What is Shire’s stock price today? One share of SHPG stock can currently be purchased for approximately $179.20. How big of a company is Shire? Shire has a market capitalization of $54.71 billion and generates $15.16 billion in revenue each year.
What kind of Medicine does Shire plc make?
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.
What is the average analyst price target for Shire?
4 equities research analysts have issued 1-year price targets for Shire’s stock. Their predictions range from $222.00 to $222.00. On average, they expect Shire’s share price to reach $222.00 in the next year. View Analyst Price Targets for Shire.
How did Takeda pay for the Shire acquisition?
In the year and a half following the JPY6 trillion acquisition of Shire plc, Takeda increased sales of its key drugs and divested non-core assets, and has used free cash flow to pay down JPY657 billion of debt, which is down 11% from just following the acquisition in fiscal 2018 ended March 2019.
Shire trades on the NASDAQ under the ticker symbol “SHPG.” What is Shire’s stock price today? One share of SHPG stock can currently be purchased for approximately $179.20. How big of a company is Shire? Shire has a market capitalization of $54.71 billion and generates $15.16 billion in revenue each year.
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.
4 equities research analysts have issued 1-year price targets for Shire’s stock. Their predictions range from $222.00 to $222.00. On average, they expect Shire’s share price to reach $222.00 in the next year. View Analyst Price Targets for Shire.
